TTP399

glucokinase activator · vTv Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TTP399, covering 2017-02-10 to 2023-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of TTP399 in Patients With Type 1 Diabetes [Phase 1, Phase 2]